Aarti Drugs

India
Hybrid — also manufactures internal programs
Small Molecule API Oral Solid Dose
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ✓ Press (3) ○ EMA GMP ✓ MHRA GMP (1) ✓ HC GMP (3)

Quick Facts: Aarti Drugs

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
India
Website
Modalities
Small Molecule API, Oral Solid Dose
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Aarti Drugs

Aarti Drugs makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Oral Solid Dose. 3 manufacturing sites registered with the U.S. FDA, Health Canada and the UK MHRA. Website: https://www.aartidrugs.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Aarti Drugs FDA Inspection History

2024-09
NAI VAI OAI
Date Site Type Observations Classification
2024-09-20
Aarti Drugs Limited
Palghar Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Aarti Drugs MHRA GMP Compliance 1 certificates

2024-06
Compliant Non-Compliant
Certificate Site City / Postcode Inspection Date Status
UK GMP 58573 Insp GMP 58573/34441740-0001[H] PINNACLE LIFE SCIENCE PRIVATE LIMITED IN-174101 2024-06-25 COMPLIANT
Source: MHRA GMDP Database · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Company Signals 3 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-10-11
Aarti Drugs Assigned BUY Rating With Rs 454 Price Target - Whalesbook
Aarti Drugs Assigned BUY Rating With Rs 454 Price Target  Whalesbook
capacity 2026-10-03
Can Aarti Drugs’ ₹600 Crore Capex Boost Margins and Capacity Through Backward Integration? - Trade Brains
Can Aarti Drugs’ ₹600 Crore Capex Boost Margins and Capacity Through Backward Integration?  Trade Brains
general 2026-10-01
Aarti Drugs appoints Rashesh C. Gogri as Chairman, Adhish P. Patil as MD - scanx.trade
Aarti Drugs appoints Rashesh C. Gogri as Chairman, Adhish P. Patil as MD  scanx.trade

Frequently Asked Questions About Aarti Drugs

How many FDA inspections does Aarti Drugs have on record?
CDMO Signal tracks 1 FDA inspection for Aarti Drugs, sourced from the FDA inspection database. See the full inspection history above.
Has Aarti Drugs received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Aarti Drugs.
Does Aarti Drugs hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 MHRA GMP certificate for Aarti Drugs.
Does Aarti Drugs have a CDMO Signal Score?
Not yet. Aarti Drugs is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Aarti Drugs for a manufacturing program?
Use the free AI matchmaker to compare Aarti Drugs against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Shilpa Medicare
India (registered sites)
Small Molecule API, Oral Solid Dose, Sterile Fill-Finish, Biologics, Peptides & Oligos
MSN Laboratories
India
Small Molecule API, Oral Solid Dose
Sri Krishna Pharmaceuticals
India
Small Molecule API, Oral Solid Dose
Indoco Remedies
Mumbai, India
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals
BDR Pharmaceuticals
Mumbai, India
Oncology Products, Oral Solid Dose, Sterile Injectables, Small Molecule API

Compare Aarti Drugs with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Aarti Drugs
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.